RxDoctor Payments Data

Warren Peters

Loma Linda, CANPI 1871680314

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Novo Nordisk accounts for 64.3% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $635, 2.6 times the $241 reported in 2019.

$1,619in general payments, 2019–2025

Across 24 payments — averaging $67.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$233
  • Sanofi-aventis U.S. LLC$122
  • Bayer$109
  • Merck$55
  • Ipsen Biopharmaceuticals, Inc$32
  • plus $27 from 1 others
$4,447,790in research payments, 2019–2025

Across 299 payments — averaging $14,876 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$3.3M
  • Novo Nordisk$1M
  • Eli Lilly$60K
  • Eli Lilly Export S.A. Puerto Rico Branch$2K

What the payments were for

  • Food & beverage$1,55496%
  • Education$654%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →